| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3332057 | Hematology/Oncology Clinics of North America | 2008 | 29 Pages |
Abstract
Non-Hodgkin's lymphoma (NHL) includes a diverse set of conditions ranging from high-grade aggressive to more indolent low-grade disease. Hematopoietic stem cell transplantation (HSCT) has a valuable role in the management of these conditions and can provide long-term remission in selected cases. This article presents the current use of allogeneic and autologous HSCT in a number of subtypes of NHL.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
David Wrench, John G. Gribben,